Current Status of
CXCR4
PET
Pentixafor
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
02 Sep 2022
02 Sep 2022
Historique:
received:
03
08
2022
accepted:
26
08
2022
entrez:
23
9
2022
pubmed:
24
9
2022
medline:
24
9
2022
Statut:
epublish
Résumé
Chemokine receptor CXCR4 is overexpressed in neoplasms and its expression is related to tumour invasion, metastasis and aggressiveness.
Identifiants
pubmed: 36140541
pii: diagnostics12092135
doi: 10.3390/diagnostics12092135
pmc: PMC9497673
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
ChemMedChem. 2011 Oct 4;6(10):1789-91
pubmed: 21780290
Clin Nucl Med. 2017 Jan;42(1):e29-e34
pubmed: 27819856
Mol Imaging Biol. 2022 Aug;24(4):659-665
pubmed: 35312939
Hepatology. 2021 Jan;73 Suppl 1:4-13
pubmed: 32319693
J Nucl Med. 2016 May;57(5):741-6
pubmed: 26769866
Cancer Res. 2002 Oct 15;62(20):5930-8
pubmed: 12384559
Pathol Res Pract. 2020 Jan;216(1):152787
pubmed: 31859114
Front Oncol. 2021 Apr 15;11:591386
pubmed: 33937018
Neurosurgery. 2008 Sep;63(3):560-9; discussion 569-70
pubmed: 18812968
World J Oncol. 2019 Apr;10(2):63-89
pubmed: 31068988
Theranostics. 2017 Apr 5;7(6):1489-1498
pubmed: 28529632
J Control Release. 2022 Jan;341:892-903
pubmed: 34953982
Dtsch Arztebl Int. 2018 Mar 16;115(11):175-181
pubmed: 29607803
J Bone Oncol. 2019 May 08;17:100239
pubmed: 31193811
ORL J Otorhinolaryngol Relat Spec. 2017;79(1-2):34-42
pubmed: 28231592
Oncotarget. 2017 May 27;8(57):96732-96737
pubmed: 29228566
Gut Liver. 2014 Mar;8(2):196-204
pubmed: 24672662
Br J Cancer. 2021 Oct;125(9):1233-1238
pubmed: 34400803
PLoS One. 2012;7(8):e43665
pubmed: 22916293
Cancer Epidemiol. 2022 Apr;77:102055
pubmed: 35026707
Oncotarget. 2016 Feb 23;7(8):9288-95
pubmed: 26843617
J Leukoc Biol. 2021 May;109(5):953-967
pubmed: 33089889
N Engl J Med. 2021 Apr 8;384(14):1335-1348
pubmed: 33826821
Front Oncol. 2019 Aug 14;9:770
pubmed: 31475113
Biochim Biophys Acta. 2007 Apr;1768(4):952-63
pubmed: 17169327
Oncogene. 2019 Feb;38(6):881-895
pubmed: 30177838
Mol Cancer. 2019 Mar 30;18(1):63
pubmed: 30927923
Ann Surg Oncol. 2017 Mar;24(3):832-840
pubmed: 26577115
EJNMMI Res. 2018 Sep 6;8(1):90
pubmed: 30191351
Oncotarget. 2017 Sep 16;8(56):95606-95619
pubmed: 29221153
J Clin Pathol. 2022 May;75(5):324-332
pubmed: 33692092
Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):50-6
pubmed: 21932117
Front Endocrinol (Lausanne). 2020 Nov 13;11:597878
pubmed: 33281749
World J Gastroenterol. 2015 Jul 14;21(26):7933-43
pubmed: 26185366
EJNMMI Radiopharm Chem. 2020 Feb 27;5(1):8
pubmed: 32107654
Tumour Biol. 2016 Jun;37(6):8169-79
pubmed: 26715277
Biomarkers. 2019 Sep;24(6):510-516
pubmed: 31244335
BMB Rep. 2014 Jan;47(1):33-8
pubmed: 24209634
J Gastrointest Oncol. 2021 Jul;12(Suppl 2):S361-S373
pubmed: 34422400
Tumour Biol. 2017 Jun;39(6):1010428317695528
pubmed: 28639900
Ann Oncol. 2005;16 Suppl 6:vi7-vi12
pubmed: 15987995
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Pers Med. 2021 Apr 30;11(5):
pubmed: 33946372
J Nucl Med. 2016 Feb;57(2):248-51
pubmed: 26564323
Insights Imaging. 2022 Jan 20;13(1):10
pubmed: 35050416
Clin Cancer Res. 2019 Apr 1;25(7):2206-2218
pubmed: 30563937
Eur J Cancer Prev. 2021 Mar 1;30(2):161-170
pubmed: 32483012
Exp Biol Med (Maywood). 2011 Jun 1;236(6):637-47
pubmed: 21565895
Int J Oncol. 2009 Mar;34(3):665-72
pubmed: 19212671
Histol Histopathol. 2020 Aug;35(8):863-870
pubmed: 32314796
Eur J Cancer. 2017 Apr;75:222-230
pubmed: 28237868
J Gastrointest Cancer. 2022 Jan 13;:
pubmed: 35023010
Cell Death Discov. 2021 May 29;7(1):126
pubmed: 34052833
Semin Cancer Biol. 2020 Oct;65:176-188
pubmed: 31874281
Cancer Epidemiol. 2013 Oct;37(5):725-31
pubmed: 23763828
Cancer Res. 2008 Nov 1;68(21):8938-44
pubmed: 18974138
Prostate. 2009 Sep 15;69(13):1460-9
pubmed: 19588526
Int J Gynecol Cancer. 2013 Jul;23(6):1111-7
pubmed: 23765204
J Pathol. 2011 Mar;223(4):519-30
pubmed: 21294125
Tumour Biol. 2014 Apr;35(4):3709-15
pubmed: 24326770
Oral Maxillofac Surg Clin North Am. 2018 Nov;30(4):381-395
pubmed: 30078696
Eur J Obstet Gynecol Reprod Biol. 2017 Jul;214:178-183
pubmed: 28535405
Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):481-491
pubmed: 33550492
Cell Signal. 2021 Nov;87:110093
pubmed: 34302955
Cancers (Basel). 2021 Nov 23;13(23):
pubmed: 34885003
Eur Urol. 2019 Jan;75(1):74-84
pubmed: 30243799
Oncol Lett. 2013 Nov;6(5):1439-1446
pubmed: 24179538
Sci Rep. 2022 Apr 6;12(1):5720
pubmed: 35388021
Mol Cancer. 2006 Nov 03;5:56
pubmed: 17083723
Cancer Res. 2006 Feb 15;66(4):2181-7
pubmed: 16489019
Cancers (Basel). 2021 Apr 01;13(7):
pubmed: 33915765
J Exp Clin Cancer Res. 2014 Dec 04;33:103
pubmed: 25471741
J Nucl Med. 2019 Oct;60(10):1399-1405
pubmed: 30850502
Am J Cancer Res. 2013;3(1):46-57
pubmed: 23359227
Appl Immunohistochem Mol Morphol. 2020 Nov/Dec;28(10):755-760
pubmed: 31985548
Oncotarget. 2018 Jan 10;9(11):9940-9950
pubmed: 29515781
Cancers (Basel). 2021 Aug 25;13(17):
pubmed: 34503097
Int J Surg. 2019 May;65:32-38
pubmed: 30902754
Int J Mol Sci. 2020 Jun 04;21(11):
pubmed: 32512697
Clin Cancer Res. 2010 Jun 1;16(11):2927-31
pubmed: 20484021
Br J Cancer. 2012 Apr 24;106(9):1520-5
pubmed: 22531719
Theranostics. 2013;3(1):47-75
pubmed: 23382786
Eur J Nucl Med Mol Imaging. 2022 Jun 8;:
pubmed: 35674738
Cells. 2021 Jun 09;10(6):
pubmed: 34207884
Curr HIV/AIDS Rep. 2012 Sep;9(3):278-86
pubmed: 22744002
Int J Surg. 2019 Nov;71:12-18
pubmed: 31494331
Oncotarget. 2015 Feb 20;6(5):3346-58
pubmed: 25671300
Int J Oncol. 2009 Feb;34(2):473-80
pubmed: 19148483
Cell Mol Immunol. 2008 Oct;5(5):373-8
pubmed: 18954561
Expert Rev Anticancer Ther. 2006 Jul;6(7):1111-8
pubmed: 16831082
Br J Cancer. 2014 Mar 4;110(5):1288-97
pubmed: 24448360
J Nucl Med. 2019 Jun;60(6):801-805
pubmed: 30954939
J Natl Cancer Inst. 2005 Dec 21;97(24):1840-7
pubmed: 16368946
Front Oncol. 2019 Jun 14;9:490
pubmed: 31259150
Cancer Imaging. 2021 Feb 12;21(1):22
pubmed: 33579381
Ann Nucl Med. 2018 Oct;32(8):503-511
pubmed: 30105558
PLoS One. 2013;8(3):e58426
pubmed: 23484027
Drug Des Devel Ther. 2015 Aug 28;9:4953-64
pubmed: 26356032
Cytokine. 2021 Dec;148:155691
pubmed: 34464923
Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1925-30
pubmed: 9050881
Transl Cancer Res. 2021 Sep;10(9):4180-4195
pubmed: 35116714
Front Oncol. 2019 Jun 12;9:503
pubmed: 31245296
Proc Natl Acad Sci U S A. 2021 Mar 30;118(13):
pubmed: 33753481
BMC Cancer. 2014 Jan 29;14:49
pubmed: 24475985
Eur J Nucl Med Mol Imaging. 2017 May;44(5):909-910
pubmed: 28110347
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Virol. 2001 Jun;75(12):5457-64
pubmed: 11356952
Clin Gastroenterol Hepatol. 2020 Mar;18(3):534-542
pubmed: 31362118
World J Gastrointest Oncol. 2021 Oct 15;13(10):1336-1366
pubmed: 34721770
Mol Pharm. 2019 May 6;16(5):2106-2117
pubmed: 30883140
Nature. 2001 Mar 1;410(6824):50-6
pubmed: 11242036
PLoS One. 2015 Jun 19;10(6):e0130192
pubmed: 26091099
PLoS One. 2014 Mar 21;9(3):e92629
pubmed: 24658065
J Nucl Med. 2022 Mar 3;:
pubmed: 35241482
Diagnostics (Basel). 2021 Mar 29;11(4):
pubmed: 33805264
Neuro Oncol. 2021 Oct 5;23(12 Suppl 2):iii1-iii105
pubmed: 34608945
FEBS Lett. 2012 Oct 19;586(20):3639-44
pubmed: 22992418
J Nucl Med. 2019 Jan;60(1):60-64
pubmed: 29777009